Analytic Neurology: Examining the Evidence for Clinical PracticeHere's an evidence-based approach to the everyday practice of neurology. Using a question-and-answer format-the same method used in the clinical setting-it focuses on the diagnosis, management, and prognosis of the most common neurologic problems through an exploration of relevant literature. Following this method, it reviews the evidence that supports clinical practice, allowing the reader to evaluate the evidence for themselves to reach an independent conclusion.
|
Contents
Risk of Ischemic Stroke Recurrence | 1 |
Antiplatelet Therapy and Ischemic Stroke | 9 |
Anticoagulants in the Treatment of Ischemic Stroke | 19 |
Copyright | |
52 other sections not shown
Common terms and phrases
abnormal ADAS-cog scores Alzheimer's Disease amongst analysis aneurysms anticonvulsant aPL antibodies aspirin associated atrial fibrillation baseline Bell's palsy carbamazepine carotid cervical CIBIC-plus clinical compared controlled trial criteria dementia disability donepezil dose double-blind drug duration dyskinesias EDSS efficacy endpoint estrogen evaluated evidence follow-up function galantamine grade Guillain-Barré Syndrome headache hemorrhage heparin high-dose improvement included initial intravenous ischemic stroke IVIg L-dopa lesions methylprednisolone mg per day migraine mild moderate months Multiple Sclerosis myasthenia gravis Neurol neurologic NSAID onset optic neuritis patients were randomized phenytoin placebo placebo group placebo-controlled trial placebo-treated plasma exchange plasmapheresis prednisone primary outcome measure randomized to receive receive placebo recurrent stroke reduced relapse relative risk risk of recurrent risk of seizure risk of stroke rivastigmine Scale secondary seizure recurrence severe significant differences spinal cord stenosis steroids stroke recurrence Study Group surgery surgical symptomatic symptoms Table therapy tive tolcapone treatment groups vasospasm warfarin